# Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

> **NCT06938152** · PHASE4 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Osteoporosis
- Osteoporosis Postmenopausal

## Interventions

- **DRUG:** Romosozumab followed by Denosumab
- **DRUG:** Romosozumab and Denosumab Cycle Therapy

## Key facts

- **NCT ID:** NCT06938152
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2029-04-30
- **Final completion:** 2029-12-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938152, "Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06938152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*